Healthy Skepticism Library item: 2460

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Healy DI.
Conflicting interests in Toronto: anatomy of a controversy at the interface of academia and industry.
Perspect Biol Med 2002 Spr; 45:(2):250-63
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11919383

Abstract:

In December 2000, the University of Toronto breached a contract it held with me, initiating a sequence of events that has led to a public letter to the University from a large number of senior figures in the psychopharmacology community, protesting against the infringement of academic freedom involved, and a first-ever legal action seeking redress for violation of academic freedom. This case has been intertwined from the start with a longer running debate about the possibility that the SSRI group of antidepressants may have the potential to trigger suicidality or other serious effects in a subgroup of takers. And this specific issue connects to concerns about conflict of interest in the domain of therapeutics, as well as in science in general, the ghostwriting of scientific articles, and a series of other hot-spots on the interface between academia and industry.

Keywords:
Biomedical Research* Conflict of Interest* Disclosure Drug Industry/economics* Humans Nontherapeutic Human Experimentation Ontario Serotonin Uptake Inhibitors/adverse effects* Suicide* Universities/economics* *analysis Canada University of Toronto Healy academic freedom antidepressants depression suicide conflict-of-interest ghost writing PROMOTION DISGUISED: GHOST-WRITING AND JOURNAL ARTICLES